Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

farma group srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - mometasonfuroat monohydrat, olopatadinhydrochlorid - næsespray, suspension - 25+600 mikrog./dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - mometasonfuroat - kutanopløsning - 0,1 %

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - mometasonfuroat - creme - 1 mg/g

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - mometasonfuroat - salve - 1 mg/g

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

n.v. organon - mometasonfuroat - inhalationspulver - 400 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - mometasonfuroat - inhalationspulver - 400 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

dymalife pharmaceutical srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

s.f. group s.r.l. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Europese Unie - Deens - EMA (European Medicines Agency)

gilead sciences ireland uc - cobicistat - hiv infektioner - antivirale midler til systemisk anvendelse - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.